Published in N Engl J Med on July 13, 2017
Surgical or Transcatheter Aortic-Valve Replacement. N Engl J Med (2017) 0.75
Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med (2017) 4.00
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med (2005) 3.60
Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesth Analg (2003) 2.32
Narrow, slow-conducting isthmus dependent left atrial reentry developing after ablation for atrial fibrillation: ECG characterization and elimination by focal RF ablation. J Cardiovasc Electrophysiol (2006) 1.69
Quantitative study of nerves of the human left atrium. Heart Rhythm (2005) 1.59
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol (2014) 1.59
QT dynamicity and sudden death after myocardial infarction: results of a long-term follow-up study. J Cardiovasc Electrophysiol (2003) 1.56
Endovascular treatment of Angio-Seal-related limb ischemia--primary results and long-term follow-up. Catheter Cardiovasc Interv (2010) 1.54
Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial. J Am Coll Cardiol (2007) 1.54
Value of P-wave signal averaging to predict atrial fibrillation recurrences after pulmonary vein isolation. Europace (2012) 1.52
Cellular actors, Toll-like receptors, and local cytokine profile in acute coronary syndromes. Eur Heart J (2010) 1.51
Feasibility of simultaneous bilateral carotid artery stenting. Catheter Cardiovasc Interv (2004) 1.50
Comparison of results of carotid stenting followed by open heart surgery versus combined carotid endarterectomy and open heart surgery (coronary bypass with or without another procedure). Am J Cardiol (2005) 1.49
2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation. Rev Esp Cardiol (Engl Ed) (2015) 1.49
Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive procedures. J Am Coll Cardiol (2011) 1.46
Superficial femoral artery occlusion: nitinol stents achieve better flow and reduce the need for medications than balloon angioplasty alone. J Invasive Cardiol (2003) 1.41
Narrow-complex tachycardia with cycle length alternans: what is the mechanism? Heart Rhythm (2008) 1.40
Postmitral valve replacement biatrial, septal macroreentrant atrial tachycardia developing after perimitral flutter ablation. Circ Arrhythm Electrophysiol (2014) 1.39
Proving the safety of carotid artery stenting: now or never. J Endovasc Ther (2012) 1.39
Prognostic value of early exercise testing after coronary stent implantation. Am J Cardiol (2008) 1.38
Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation (2005) 1.36
Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes. Eur Heart J (2007) 1.31
Introduction of new industry standards for cardiac implantable electronic devices: balancing benefits and unexpected risks. Europace (2012) 1.22
Local versus general anesthesia for transcatheter aortic valve implantation (TAVR)--systematic review and meta-analysis. BMC Med (2014) 1.21
Diagnostic accuracy of pocket-size handheld echocardiographs used by cardiologists in the acute care setting. Eur Heart J Cardiovasc Imaging (2012) 1.09
Acute pyloric spasm and gastric hypomotility: an extracardiac adverse effect of percutaneous radiofrequency ablation for atrial fibrillation. J Am Coll Cardiol (2005) 1.08
Perioperative outcome and long-term survival of surgery for acute post-infarction mitral regurgitation. Eur J Cardiothorac Surg (2004) 1.06
Platypnea-orthodeoxia syndrome in the elderly treated by percutaneous patent foramen ovale closure: a case series and literature review. Eur J Intern Med (2013) 1.03
Endovascular treatment of carotid artery aneurysms with stent grafts. J Invasive Cardiol (2002) 1.02
Pulmonary arterial hypertension in patients with transcatheter closure of secundum atrial septal defects: a longitudinal study. Circ Cardiovasc Interv (2009) 0.95
Prevention of implantable defibrillator shocks by cognitive behavioral therapy: a pilot trial. Am Heart J (2006) 0.95
The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) randomized controlled trial: phase 1 results on dynamics of early intervention with remote monitoring. J Med Internet Res (2013) 0.95
Pacing of the interventricular septum versus the right ventricular apex: a prospective, randomized study. Eur J Intern Med (2012) 0.93
High-density lipoprotein/apolipoprotein A-I infusion therapy. Curr Atheroscler Rep (2009) 0.91
Percutaneous treatment for pacemaker-associated superior vena cava syndrome. Pacing Clin Electrophysiol (2002) 0.91
Pharmacologic preconditioning therapy prior to atrial septal defect closure in patients at high risk for acute pulmonary edema. J Interv Cardiol (2012) 0.91
Identifying far-field superior vena cava potentials within the right superior pulmonary vein. Heart Rhythm (2006) 0.90
[2014 ESC Guidelines on the diagnosis and treatment of aortic diseases]. Kardiol Pol (2014) 0.90
Evaluation of right atrial size in patients with atrial arrhythmias: comparison of 2D versus real time 3D echocardiography. Echocardiography (2008) 0.90
Biatrial anatomical reverse remodelling after radiofrequency catheter ablation for atrial fibrillation: evidence from real-time three-dimensional echocardiography. Europace (2008) 0.88
New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association. Europace (2013) 0.88
Role of rheolytic thrombectomy in massive pulmonary embolism with contraindication to systemic thrombolytic therapy. EuroIntervention (2010) 0.88
Carotid artery stenting versus surgery: adequate comparisons? Lancet Neurol (2010) 0.87
Transradial access for peripheral and cerebrovascular interventions. J Invasive Cardiol (2013) 0.87
Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis. J Am Coll Cardiol (2003) 0.87
Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccine. Antivir Ther (2012) 0.87
Ventricular mechanical dyssynchrony and resynchronization therapy in heart failure: a new indication for Fourier analysis of gated blood-pool radionuclide ventriculography. Nucl Med Commun (2006) 0.86
Short-term clinical outcomes among patients undergoing transcatheter aortic valve implantation in Switzerland: the Swiss TAVI registry. EuroIntervention (2014) 0.86
Rapid progression of left main coronary disease causing acute coronary syndrome. Ann Thorac Surg (2011) 0.84
Device therapy and hospital reimbursement practices across European countries: a heterogeneous scenario. Europace (2011) 0.84
Postpartal dissection of all coronary arteries in an in vitro-fertilized postmenopausal woman. Tex Heart Inst J (2009) 0.83
Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. Europace (2014) 0.83
Outcome of multivessel coronary intervention in the contemporary percutaneous revascularization era. Am J Cardiol (2006) 0.82
AngioJet rheolytic thrombectomy in patients presenting with high-risk pulmonary embolism and cardiogenic shock: a feasibility pilot study. EuroIntervention (2013) 0.81
Usefulness of P-wave signal averaging to predict atrial fibrillation recurrences after electrical cardioversion. Ann Noninvasive Electrocardiol (2014) 0.81
Sirolimus eluting stent: a new era in interventional cardiology? Curr Pharm Des (2003) 0.81
Severe bilateral carotid stenosis: the impact of ipsilateral stenting on Doppler-defined contralateral stenosis. J Am Coll Cardiol (2004) 0.81
Comparison of biolimus eluted from an erodible stent coating with bare metal stents in acute ST-elevation myocardial infarction (COMFORTABLE AMI trial): rationale and design. EuroIntervention (2012) 0.81
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur J Heart Fail (2016) 0.81
Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization: the TiNOX trial. Circulation (2005) 0.80
Carotid brachytherapy for in-stent restenosis. Catheter Cardiovasc Interv (2003) 0.80
Coronary to pulmonary artery fistulas: an incidental finding with challenging therapeutic options. J Invasive Cardiol (2011) 0.80
A new electrocardiogram algorithm for diagnosing loss of ventricular capture during cardiac resynchronisation therapy. Europace (2012) 0.80
Percutaneous PFO closure with Amplatzer PFO occluder: predictors of residual shunts at 6 months follow-up. Congenit Heart Dis (2009) 0.79
Plasma homocysteine levels and late outcome after coronary angioplasty. J Am Coll Cardiol (2002) 0.79
Questions and answers on coronary revascularization: a companion document of the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J (2015) 0.78
The quest for an optimal left ventricular lead position for cardiac resynchronization therapy. Heart Rhythm (2006) 0.78
Angiojet rheolytic thrombectomy in massive pulmonary embolism: locally efficacious but systemically deleterious? J Vasc Interv Radiol (2010) 0.78
Evaluation of left atrial size in patients with atrial arrhythmias: comparison of standard 2D versus real time 3D echocardiography. Echocardiography (2007) 0.78
Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trial. EuroIntervention (2016) 0.78
Fatal coronary sinus and aortic erosions following percutaneous transvenous mitral annuloplasty device. EuroIntervention (2011) 0.78
Thromboembolic events 7-11 years after catheter ablation of atrial fibrillation. Pacing Clin Electrophysiol (2015) 0.78
Effect of homocysteine-lowering therapy on restenosis after percutaneous coronary intervention for narrowings in small coronary arteries. Am J Cardiol (2003) 0.78
Transcatheter aortic valve implantation in nonagenarians: effective and safe. Eur J Intern Med (2013) 0.78
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction. EuroIntervention (2016) 0.78
Comparison of the safety and efficacy of emboli prevention devices versus platelet glycoprotein IIb/IIIa inhibition during carotid stenting. Am J Cardiol (2005) 0.78
Evaluation of an individualized strategy of cavotricuspid isthmus ablation as an adjunct to atrial fibrillation ablation. J Cardiovasc Electrophysiol (2007) 0.78
Complete section of pacemaker lead due to subclavian crush. Med J Aust (2005) 0.77
Sirolimus-eluting stenting of the external carotid artery for the treatment of ocular ischemia. J Endovasc Ther (2006) 0.77
Carotid artery stenting: a single center "real world" experience. PLoS One (2012) 0.77
Novel doppler assessment of intracoronary volumetric flow reserve: validation against PET in patients with or without flow-dependent vasodilation. J Nucl Med (2005) 0.77
Correlation of point-of-care ecarin clotting time versus activated clotting time with bivalirudin concentrations. Am J Cardiol (2003) 0.77
Current strategies with high-dose tirofiban. Expert Opin Drug Metab Toxicol (2007) 0.77
Late tamponade secondary to aortic root perforation by BioSTAR septal closure device. Ann Thorac Surg (2011) 0.77
Glycoprotein IIb/IIIa receptor inhibitors in 2008: do they still have a role? J Interv Cardiol (2008) 0.77
Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis. EuroIntervention (2017) 0.76
[2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)]. G Ital Cardiol (Rome) (2016) 0.76
Measurement of left ventricular ejection fraction by real time 3D echocardiography in patients with severe systolic dysfunction: comparison with radionuclide angiography. Echocardiography (2009) 0.76
Chronic total occlusions in non-infarct-related arteries. Eur Heart J (2012) 0.76
Paced QRS morphology for confirming septal pacemaker lead implantation: correction of a misconception. Europace (2010) 0.76